17.12.2014 - Auspex Pharmaceuticals tries to continue to grow within the channel

Auspex Pharmaceuticals stock price shows a decline of volatility and is consolidating within the corridor 23,00-25,00. The price growth in the near future is limited by the resistance level at 27.00. In case of reduction and breaking through the level of 21.00 and the bottom of the channel, we recommend to open short positions with a target at 15.00. We predict a gradual decline in prices in the near future to the level of 21.00.

RISK WARNING: Trading of complex financial products, such as Stocks, Futures, Foreign Exchange ("Forex"), Contracts for Difference ("CFDs"), Indices, Options, or other financial derivatives, on "margin" carries a high level of risk, and may not be suitable for all investors. The possibility exists that you could sustain a loss of some or all of your initial investment and, therefore, you should not invest money that you cannot afford to lose. You should be aware of all the risks associated with trading these markets, and seek advice from an independent financial advisor if you have any questions or doubts. Please carefully read our full "Risk Disclosure" and "Risk Disclosures for Financial Instruments & Investment Services". FXFINPRO Capital is the trading name of PFX Financial Professionals Limited, a limited liability company formed under the laws of Cyprus, registered with the Registrar of Companies in Nicosia, Cyprus, under nr. HE 237840 and regulated by the Cyprus Securities and Exchange Commission with license number 193/13.